EFDEGE

This brand name is authorized in Austria, France, Croatia, Malta, Poland

Active ingredients

The drug EFDEGE contains one active pharmaceutical ingredient (API):

1 Fludeoxyglucose ¹⁸F UNII 0Z5B2CJX4D - FLUDEOXYGLUCOSE F-18

Fludeoxyglucose F18 is a glucose analog that concentrates in cells that rely upon glucose as an energy source, or in cells whose dependence on glucose increases under pathophysiological conditions. Fludeoxyglucose F18 is used to assess glucose metabolism. It is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging. Read about Fludeoxyglucose ¹⁸F

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IX04	Fludeoxyglucose (18F)	V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 68460368
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-199234710
Country: MT	Medicines Authority	Identifier(s): MA1491/00101, MA1491/00102
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100159772